Lantheus Holdings, Inc. Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (11 lists). Names and jurisdictions are as filed.
- 2023-02-23: Subsidiary Lantheus Medical Imaging, Inc.; Jurisdiction Delaware.
- 2023-02-23: Subsidiary Lantheus MI Canada, Inc.; Jurisdiction Canada.
- 2023-02-23: Subsidiary Lantheus MI Real Estate, LLC; Jurisdiction Delaware.
- 2023-02-23: Subsidiary Lantheus MI UK Limited; Jurisdiction England and Wales.
| Annual report filed | Subsidiary | Jurisdiction |
|---|---|---|
| 2023-02-23 | Lantheus Medical Imaging, Inc. | Delaware |
| 2023-02-23 | Lantheus MI Canada, Inc. | Canada |
| 2023-02-23 | Lantheus MI Real Estate, LLC | Delaware |
| 2023-02-23 | Lantheus MI UK Limited | England and Wales |
| 2023-02-23 | Lantheus EU Limited | Ireland |
| 2023-02-23 | Lantheus Two, LLC | Delaware |
| 2023-02-23 | Lantheus Three, LLC | Delaware |
| 2023-02-23 | Progenics Pharmaceuticals, Inc. | Delaware |
| 2023-02-23 | Molecular Insight Pharmaceuticals, Inc. | Delaware |
| 2023-02-23 | MNTX Royalties Sub LLC | Delaware |
| 2023-02-23 | EXINI Diagnostics AB | Sweden |
| 2023-02-23 | Excelsior Life Sciences Ireland Limited | Ireland |
| 2023-02-23 | Progenics Pharmaceuticals Nevada, Inc. | Nevada |
| 2023-02-23 | PSMA Development Company LLC | Delaware |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |